As the key enzyme catalyzing the conversion of OAA into PEP, PCK1 overexpression could elevate PEP levels in T cells under glucose-limited conditions to enhance the anti-tumor effect of tumor-specific CD4+ T cells. This evidence concerns the gene CD4 and neoplasm.